Janssen Vaccines & Prevention
GPTKB entity
Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Johnson_&_Johnson_in_1961
|
| gptkbp:aimsTo |
prevent diseases
|
| gptkbp:collaboratesWith |
various research institutions
|
| gptkbp:contributedTo |
global vaccination efforts
|
| gptkbp:develops |
therapeutics
|
| gptkbp:employs |
scientists
|
| gptkbp:engagesIn |
public health initiatives
|
| gptkbp:focusesOn |
vaccine development
viral diseases |
| gptkbp:foundedBy |
gptkb:Janssen_Pharmaceutica
|
| gptkbp:hasAccreditation |
regulatory approvals
|
| gptkbp:hasCollaboratedWith |
non-profit organizations
international health bodies |
| gptkbp:hasDeveloped |
Ebola vaccine
HIV vaccine candidates Zika virus vaccine candidates malaria vaccine candidates tuberculosis vaccine candidates |
| gptkbp:hasEstablished |
manufacturing facilities
partnerships with universities clinical research networks global health partnerships |
| gptkbp:hasEvents |
significant milestones in vaccine development
FDA_approvals_for_vaccines |
| gptkbp:hasFunding |
vaccine innovation
|
| gptkbp:hasLocalCuisine |
various vaccine candidates
|
| gptkbp:hasPart |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:hasParticipatedIn |
in multiple countries
vaccine trials global vaccination campaigns |
| gptkbp:hasPartnershipsWith |
government agencies
|
| gptkbp:hasResearchFocus |
infectious diseases
|
| gptkbp:headquarters |
gptkb:Leiden,_Netherlands
|
| https://www.w3.org/2000/01/rdf-schema#label |
Janssen Vaccines & Prevention
|
| gptkbp:isActiveIn |
vaccine research and development
|
| gptkbp:isEngagedIn |
community health initiatives
research collaborations COVID-19 response efforts vaccine education initiatives |
| gptkbp:isFocusedOn |
global health challenges
preventing infectious diseases public health solutions |
| gptkbp:isInvolvedIn |
clinical research
global health partnerships vaccine distribution efforts vaccine policy discussions vaccine safety research |
| gptkbp:isKnownFor |
collaborative research efforts
innovative vaccine technologies rapid vaccine development capabilities single-dose vaccines |
| gptkbp:isPartOf |
gptkb:Johnson_&_Johnson's_pharmaceutical_segment
Johnson_&_Johnson's_global_health_strategy Johnson_&_Johnson's_COVID-19_vaccine_initiative Johnson_&_Johnson's_vaccine_portfolio |
| gptkbp:isRecognizedBy |
health organizations
|
| gptkbp:isRecognizedFor |
contributions to immunization programs
scientific advancements in vaccines |
| gptkbp:isSupportedBy |
scientific research
|
| gptkbp:notableEvent |
Johnson_&_Johnson_COVID-19_vaccine
|
| gptkbp:operatesIn |
global market
|
| gptkbp:parentCompany |
gptkb:Johnson_&_Johnson
|
| gptkbp:provides |
vaccines for public health
|